Biesterfeld expands its Executive Board


Biesterfeld AG expands its Executive Board from two to four members: beside Birger Kuck, CEO, and Christian Wolfsohn, CFO, Thomas Arnold, Managing Director of Biesterfeld Spezialchemie, and Carsten Harms, Managing Director of Biesterfeld Plastic, join the Executive Board, with immediate effect.
"With this decision the Supervisory Board emphasizes the importance of the operative businesses within the Group and in the Executive Board. We want to give the plastic and the chemicals activities an own voice in the executive board of Biesterfeld AG", explains Dirk Biesterfeld, chairman of the Supervisory Board. Arnold and Harms assume their function in the Executive Board with immediate effect while continuing in their resp. position as Managing Directors within the Biesterfeld Group.
Arnold (54) joined Biesterfeld in May 2013 as Managing Director of Biesterfeld Spezialchemie. Prior to this he held management positions in various renowned, international companies in the trade. Harms (48) has been with Biesterfeld since his trainee. He has driven the development of Biesterfeld Plastic as a one of the leading European distributors for plastics and rubber forward, since 2007 in the position as managing director of Biesterfeld Plastic.
most read

Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

Boehringer Ingelheim Paves the Way for Important Market Launches
Boehringer Ingelheim recorded positive growth in the first half of 2025 with an increase in Group sales of 6.3% to € 14 billion.

Asahi Kasei Expands Planova Production with New Spinning Plant
Asahi Kasei Life Science, a division of global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova virus removal filters in Nobeoka City, Miyazaki, Japan.

VCI Welcomes US-EU Customs Deal
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Novo Nordisk Invests $1.09 Billion in Brazil
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.